S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
Critical asset just had biggest fall on record (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Critical asset just had biggest fall on record (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
NASDAQ:CYRX

Cryoport (CYRX) Stock Price, News & Analysis

$17.91
+0.24 (+1.36%)
(As of 03/1/2024 ET)
Today's Range
$17.63
$18.59
50-Day Range
$14.27
$17.67
52-Week Range
$9.00
$24.30
Volume
532,105 shs
Average Volume
319,569 shs
Market Capitalization
$876.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.14

Cryoport MarketRank™ Stock Analysis

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
1.3% Upside
$18.14 Price Target
Short Interest
Bearish
8.87% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of Cryoport in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$29,012 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.16) to ($0.97) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.63 out of 5 stars

Transportation Sector

111th out of 117 stocks

Pharmaceutical Preparations Industry

414th out of 440 stocks


CYRX stock logo

About Cryoport Stock (NASDAQ:CYRX)

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

CYRX Stock Price History

CYRX Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Matson, Inc. (MATX)
MATX Jun 2024 80.000 put
MATX Mar 2024 100.000 call
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Should You Buy CryoPort, Inc. (CYRX) After Golden Cross?
BTIG Keeps Their Buy Rating on CryoPort (CYRX)
BTIG Reaffirms Their Buy Rating on CryoPort (CYRX)
Cryoport acquires New York-based transport company
Cryoport Reports Third Quarter 2023 Financial Results
Here's what Wall Street expects from CryoPort's earnings
See More Headlines
Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
3/02/2024
Next Earnings (Confirmed)
3/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
1,024
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.14
High Stock Price Target
$28.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+1.3%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

Net Income
$-37,330,000.00
Pretax Margin
-18.43%

Debt

Sales & Book Value

Annual Sales
$236.35 million
Book Value
$10.97 per share

Miscellaneous

Free Float
43,823,000
Market Cap
$876.95 million
Optionable
Optionable
Beta
1.58
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report














CYRX Stock Analysis - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CYRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CYRX, but not buy additional shares or sell existing shares.
View CYRX analyst ratings
or view top-rated stocks.

What is Cryoport's stock price target for 2024?

6 Wall Street research analysts have issued 1-year price targets for Cryoport's shares. Their CYRX share price targets range from $10.00 to $28.00. On average, they anticipate the company's stock price to reach $18.14 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts price targets for CYRX
or view top-rated stocks among Wall Street analysts.

How have CYRX shares performed in 2024?

Cryoport's stock was trading at $15.49 at the beginning of 2024. Since then, CYRX stock has increased by 15.6% and is now trading at $17.91.
View the best growth stocks for 2024 here
.

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 12th 2024.
View our CYRX earnings forecast
.

How can I listen to Cryoport's earnings call?

Cryoport will be holding an earnings conference call on Tuesday, March 12th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "33425097 #".

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) posted its quarterly earnings data on Wednesday, November, 8th. The company reported ($0.31) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.31). The company had revenue of $56.16 million for the quarter, compared to analysts' expectations of $55.24 million. Cryoport had a negative net margin of 19.73% and a negative trailing twelve-month return on equity of 8.83%. Cryoport's revenue for the quarter was down 7.1% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.15) EPS.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

Who are Cryoport's major shareholders?

Cryoport's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (13.80%), Vanguard Group Inc. (7.47%), Cadian Capital Management LP (7.08%), Massachusetts Financial Services Co. MA (4.07%), New York State Common Retirement Fund (3.36%) and Assenagon Asset Management S.A. (2.85%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends
.

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CYRX) was last updated on 3/2/2024 by MarketBeat.com Staff